Verition Fund Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-128,120
| Closed | -$1.31M | – | 2396 |
|
|
2023
Q2 | $1.31M | Hold |
128,120
| – | – | 0.02% | 723 |
|
|
2023
Q1 | $1.3M | Hold |
128,120
| – | – | 0.02% | 768 |
|
|
2022
Q4 | $1.28M | Hold |
128,120
| – | – | 0.02% | 677 |
|
|
2022
Q3 | $1.25M | Hold |
128,120
| – | – | 0.01% | 1026 |
|
|
2022
Q2 | $1.24M | Buy |
128,120
+34,100
| +36% | +$330K | 0.02% | 889 |
|
|
2022
Q1 | $917K | Buy |
+94,020
| New | +$917K | 0.01% | 1016 |
|